vs

Side-by-side financial comparison of BWX Technologies, Inc. (BWXT) and ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION). Click either name above to swap in a different company.

ZIONS BANCORPORATION, NATIONAL ASSOCIATION is the larger business by last-quarter revenue ($891.0M vs $885.8M, roughly 1.0× BWX Technologies, Inc.). ZIONS BANCORPORATION, NATIONAL ASSOCIATION runs the higher net margin — 29.5% vs 10.5%, a 19.0% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs 8.7%). ZIONS BANCORPORATION, NATIONAL ASSOCIATION produced more free cash flow last quarter ($952.0M vs $56.8M). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 9.6%).

BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.

Zions Bancorporation is an American national bank headquartered in Salt Lake City, Utah. It operates as a national bank rather than as a bank holding company and does business under the following seven brands: Zions Bank, Amegy Bank of Texas, California Bank and Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and the Commerce Bank of Washington.

BWXT vs ZION — Head-to-Head

Bigger by revenue
ZION
ZION
1.0× larger
ZION
$891.0M
$885.8M
BWXT
Growing faster (revenue YoY)
BWXT
BWXT
+10.0% gap
BWXT
18.7%
8.7%
ZION
Higher net margin
ZION
ZION
19.0% more per $
ZION
29.5%
10.5%
BWXT
More free cash flow
ZION
ZION
$895.2M more FCF
ZION
$952.0M
$56.8M
BWXT
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
21.1%
9.6%
ZION

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BWXT
BWXT
ZION
ZION
Revenue
$885.8M
$891.0M
Net Profit
$93.0M
$263.0M
Gross Margin
Operating Margin
10.4%
Net Margin
10.5%
29.5%
Revenue YoY
18.7%
8.7%
Net Profit YoY
30.9%
21.8%
EPS (diluted)
$1.02
$1.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWXT
BWXT
ZION
ZION
Q4 25
$885.8M
$891.0M
Q3 25
$866.3M
$861.0M
Q2 25
$764.0M
$838.0M
Q1 25
$682.3M
$795.0M
Q4 24
$746.3M
$820.0M
Q3 24
$672.0M
$792.0M
Q2 24
$681.5M
$777.0M
Q1 24
$604.0M
$742.0M
Net Profit
BWXT
BWXT
ZION
ZION
Q4 25
$93.0M
$263.0M
Q3 25
$82.1M
$222.0M
Q2 25
$78.4M
$244.0M
Q1 25
$75.5M
$170.0M
Q4 24
$71.0M
$216.0M
Q3 24
$69.5M
$214.0M
Q2 24
$73.0M
$201.0M
Q1 24
$68.5M
$153.0M
Gross Margin
BWXT
BWXT
ZION
ZION
Q4 25
Q3 25
21.8%
Q2 25
25.1%
Q1 25
24.2%
Q4 24
Q3 24
24.4%
Q2 24
24.7%
Q1 24
24.6%
Operating Margin
BWXT
BWXT
ZION
ZION
Q4 25
10.4%
Q3 25
13.1%
Q2 25
13.4%
Q1 25
14.2%
Q4 24
12.4%
Q3 24
14.4%
Q2 24
14.5%
Q1 24
15.4%
Net Margin
BWXT
BWXT
ZION
ZION
Q4 25
10.5%
29.5%
Q3 25
9.5%
25.8%
Q2 25
10.3%
29.1%
Q1 25
11.1%
21.4%
Q4 24
9.5%
26.3%
Q3 24
10.3%
27.0%
Q2 24
10.7%
25.9%
Q1 24
11.3%
20.6%
EPS (diluted)
BWXT
BWXT
ZION
ZION
Q4 25
$1.02
$1.77
Q3 25
$0.89
$1.48
Q2 25
$0.85
$1.63
Q1 25
$0.82
$1.13
Q4 24
$0.77
$1.34
Q3 24
$0.76
$1.37
Q2 24
$0.79
$1.28
Q1 24
$0.75
$0.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWXT
BWXT
ZION
ZION
Cash + ST InvestmentsLiquidity on hand
$499.8M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.2B
$7.2B
Total Assets
$4.3B
$89.0B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWXT
BWXT
ZION
ZION
Q4 25
$499.8M
Q3 25
$79.6M
Q2 25
$37.0M
Q1 25
$55.4M
Q4 24
$74.1M
Q3 24
$35.5M
Q2 24
$48.3M
Q1 24
$45.9M
Total Debt
BWXT
BWXT
ZION
ZION
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$970.0M
Q1 25
$964.0M
Q4 24
$950.0M
Q3 24
$548.0M
Q2 24
$546.0M
Q1 24
$544.0M
Stockholders' Equity
BWXT
BWXT
ZION
ZION
Q4 25
$1.2B
$7.2B
Q3 25
$1.2B
$6.9B
Q2 25
$1.2B
$6.6B
Q1 25
$1.1B
$6.3B
Q4 24
$1.1B
$6.1B
Q3 24
$1.1B
$6.4B
Q2 24
$998.5M
$6.0B
Q1 24
$946.2M
$5.8B
Total Assets
BWXT
BWXT
ZION
ZION
Q4 25
$4.3B
$89.0B
Q3 25
$3.8B
$88.5B
Q2 25
$3.7B
$88.9B
Q1 25
$3.1B
$88.0B
Q4 24
$2.9B
$88.8B
Q3 24
$2.9B
$87.0B
Q2 24
$2.8B
$87.6B
Q1 24
$2.8B
$87.1B
Debt / Equity
BWXT
BWXT
ZION
ZION
Q4 25
0.21×
Q3 25
0.21×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.16×
Q3 24
0.09×
Q2 24
0.09×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWXT
BWXT
ZION
ZION
Operating Cash FlowLast quarter
$127.0M
$1.1B
Free Cash FlowOCF − Capex
$56.8M
$952.0M
FCF MarginFCF / Revenue
6.4%
106.8%
Capex IntensityCapex / Revenue
7.9%
13.6%
Cash ConversionOCF / Net Profit
1.37×
4.08×
TTM Free Cash FlowTrailing 4 quarters
$295.3M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWXT
BWXT
ZION
ZION
Q4 25
$127.0M
$1.1B
Q3 25
$143.2M
$438.0M
Q2 25
$159.0M
$-62.0M
Q1 25
$50.6M
$179.0M
Q4 24
$276.9M
$1.1B
Q3 24
$32.6M
$119.0M
Q2 24
$65.9M
$251.0M
Q1 24
$33.0M
$261.0M
Free Cash Flow
BWXT
BWXT
ZION
ZION
Q4 25
$56.8M
$952.0M
Q3 25
$94.9M
$413.0M
Q2 25
$126.3M
$-93.0M
Q1 25
$17.3M
$152.0M
Q4 24
$224.4M
$1.1B
Q3 24
$-7.7M
$97.0M
Q2 24
$35.5M
$234.0M
Q1 24
$2.6M
$231.0M
FCF Margin
BWXT
BWXT
ZION
ZION
Q4 25
6.4%
106.8%
Q3 25
11.0%
48.0%
Q2 25
16.5%
-11.1%
Q1 25
2.5%
19.1%
Q4 24
30.1%
128.2%
Q3 24
-1.1%
12.2%
Q2 24
5.2%
30.1%
Q1 24
0.4%
31.1%
Capex Intensity
BWXT
BWXT
ZION
ZION
Q4 25
7.9%
13.6%
Q3 25
5.6%
2.9%
Q2 25
4.3%
3.7%
Q1 25
4.9%
3.4%
Q4 24
7.0%
11.8%
Q3 24
6.0%
2.8%
Q2 24
4.5%
2.2%
Q1 24
5.0%
4.0%
Cash Conversion
BWXT
BWXT
ZION
ZION
Q4 25
1.37×
4.08×
Q3 25
1.74×
1.97×
Q2 25
2.03×
-0.25×
Q1 25
0.67×
1.05×
Q4 24
3.90×
5.31×
Q3 24
0.47×
0.56×
Q2 24
0.90×
1.25×
Q1 24
0.48×
1.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWXT
BWXT

Nuclear Component Program$436.4M49%
Nuclear Manufacturing$134.8M15%
Cost Plus Fee$116.1M13%
Uranium And Nuclear Services$103.8M12%
Commercial Operations$49.0M6%
Commercial Operations Segment$33.7M4%
Transferred At Point In Time$1.3M0%

ZION
ZION

Segment breakdown not available.

Related Comparisons